The Food and Drug Administration approved a breakthrough pancreatic cancer treatment, found to double survival to thirteen months compared to people who just got chemotherapy. It’s called Rasonque, and it’s approved for patients with advanced pancreatic cancer. NBC News’ Anne Thompson reports.
For more context and news coverage of the most important stories of our day, click here:
» Subscribe to NBC News:
» Subscribe to Here’s the Scoop podcast:
» NBC News App:
» Breaking News Alerts:
» Visit NBCNews.Com:
» Find NBC News on Facebook:
» Follow NBC News on Twitter:
» Follow NBC News on Instagram:
#medicine #news #cancer
source

























